Results 51 to 60 of about 41,228 (229)
Hepatitis-Associated Aplastic Anemia
Hepatitis-associated aplastic anemia (HAAA) is a rare illness, characterized by onset of pancytopenia with a hypoplastic bone marrow that traditionally occurs within 6 months of an increase in serum aminotransferases. HAAA is observed in 1% to 5% of all newly diagnosed cases of acquired aplastic anemia.
Alshaibani A.+4 more
openaire +5 more sources
Several regulatory initiatives have been made to clarify the acceptability and requirements of real‐world data and real‐world evidence (RWD/E) for the benefit/risk assessment of new medical products in Japan. The objectives of this review were to characterize the use of RWD/E in regulatory applications of new medical products and to describe the ...
Suguru Okami+2 more
wiley +1 more source
Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective Studies [PDF]
Hematopoietic stem cell transplantation (HSCT) is a curative therapy for severe aplastic anemia (SAA); however, the optimal conditioning regimen for HSCT with an unrelated donor has not yet been defined.
���������
core +1 more source
Abstract Anemia affects 32 million pregnant women globally, contributing annually to more than 115 000 maternal deaths and 591 000 perinatal deaths worldwide. Low‐ and middle‐income countries (LMICs) bear the highest burden of anemia in pregnancy, with nearly 50% of affected pregnant women. It is now 2025, which is WHO's target year for a 50% reduction
Akaninyene E. Ubom+9 more
wiley +1 more source
Clinical utility of hematological parameters in aplastic anemia
Hematological parameters available on automated hematology analyzers have been shown to be useful indicators for hematological disorders. However, extensive studies especially in aplastic anemia for these indices are sparse.
Lizhong Zhang+4 more
doaj +1 more source
Scurvy is a rare nutritional deficiency disease which is less likely to be suspected and it mostly lead to delayed diagnosis. It can present with features which can mislead clinicians to misdiagnose the condition as leukemia or aplastic anemia.
Harold L. Mashauri
doaj +1 more source
Показатели обмена глюкозы в эритроцитах при отдельных гематологических заболеваниях [PDF]
Установлено, що за еритремії, апластичній анемії та залізодефіцитній анемії в еритроцитах відбувається інтенсифікація гліколітичних реакцій, про що свідчить підвищення активності гексокінази і вмісту метаболіту гліколізу – фосфоенолпірувату, а також ...
Казакова, В.В.+2 more
core
Dysfunctional telomeres in primary cells from Fanconi anemia FANCD2 patients [PDF]
© 2012 Joksic et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium ...
Guc-Scekic, M+11 more
core +3 more sources
Nitrogen‐doped graphene quantum dots (N‐GQDs) were anchored onto screen‐printed carbon electrodes to selectively preconcentrate chloramphenicol (CAP). Enhanced electrochemical profiles and pH‐sensitive responses—highlight NGQD‐facilitated charge‐transfer behavior, reinforcing its potential in CAP monitoring within livestock feed and broader ...
Hwei‐yan Tsai+5 more
wiley +1 more source
Response of Paroxysmal Nocturnal Hemoglobinuria Clone with Aplastic Anemia to Rituximab
Paroxysmal nocturnal hemoglobinuria is caused by expansion of a hematopoietic stem cell clone with an acquired somatic mutation in the PIG-A gene. This mutation aborts the synthesis and expression of the glycosylphosphatidylinositol anchor proteins CD55
Radha Raghupathy, Olga Derman
doaj +1 more source